Merdad Parsey - Nov 10, 2021 Form 4 Insider Report for GILEAD SCIENCES INC (GILD)

Role
Chief Medical Officer
Signature
/s/ Amy Kim by Power of Attorney for Merdad Parsey
Stock symbol
GILD
Transactions as of
Nov 10, 2021
Transactions value $
-$156,182
Form type
4
Date filed
11/12/2021, 05:01 PM
Previous filing
Aug 24, 2021
Next filing
Jan 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Options Exercise +5.1K +36.22% 19.2K Nov 10, 2021 Direct F1
transaction GILD Common Stock Tax liability -$156K -2.32K -12.1% $67.32 16.9K Nov 10, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Restricted Stock Unit Options Exercise -5.1K -13.71% 32.1K Nov 10, 2021 Common Stock 5.1K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
F2 The restricted stock units have a three year vesting schedule. 33.33% will vest on each yearly anniversary of the date of grant until fully vested.